According to Calliditas Therapeutics's latest financial reports and stock price the company's current Operating Margin is -56.67%. At the end of 2021 the company had an Operating Margin of -223.84%.
Year | Operating Margin | Change |
---|---|---|
2021 | -223.84% | -99.55% |
2020 | -49,902.86% | 283691.14% |
2019 | -17.58% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.